Literature DB >> 7892833

Workers' compensation for nonmalignant asbestos-related lung disease.

C Nevitt1, W Daniell, L Rosenstock.   

Abstract

Workers' compensation claims filed for occupational illness are generally more complicated to resolve than are injury claims, and they may therefore face higher likelihood of rejection. This study analyzed outcomes and predictive factors for claims filed from one clinic in Washington State between 1982 and 1986 by 157 male patients for nonmalignant asbestos-related lung disease. Among 50 federal Longshore claims, 46 (92%) were unresolved or could not be located by claims administrators. In contrast, 118 (89%) of State Fund claims had been resolved, with 48% accepted without consistent relationship to disease severity. Claims filed under both jurisdictions showed a twofold greater risk of rejection by the State Fund (relative risk, RR = 2.0; 95% confidence interval, 95% CI = 1.3-3.2). State Fund claims filed for nonwhite patients were rejected more often than those of white patients, although the association was explained at least partially by jurisdictional overlap (adjusted RR = 1.5; 95% CI = 1.05-2.1). This study indicates a need to scrutinize the handling of occupational disease claims by the federal Longshore system and to consider the adverse influences of jurisdictional conflicts and possible race-associated factors on compensation of occupational illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892833     DOI: 10.1002/ajim.4700260611

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Racial and ethnic variations in office-based medical care for work-related injuries and illnesses.

Authors:  Allard E Dembe; Judith A Savageau; Benjamin C Amick; Steven M Banks
Journal:  J Natl Med Assoc       Date:  2005-04       Impact factor: 1.798

2.  Work-related injury burden, workers' compensation claim filing, and barriers: Results from a statewide survey of janitors.

Authors:  Naomi J Anderson; Caroline K Smith; Michael P Foley
Journal:  Am J Ind Med       Date:  2021-12-13       Impact factor: 3.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.